0
Skip to Content
Thryv Therapeutics
About Us
Thryv Team
Board of Directors
Scientific Advisory Board
Our Investors
Join Us
Pipeline R&D
Pipeline
SGK1 Inhibition
Clinical Studies
Publications
Presentations
Focus Areas
Long QT Syndrome (LQTS)
Heart Failure
Atrial Fibrillation
Acquired Long QT
News & Info
Press Releases
Shared Stories & Blog
Contact
Region
Canada: English
Canada: Français
United States
Thryv Therapeutics
About Us
Thryv Team
Board of Directors
Scientific Advisory Board
Our Investors
Join Us
Pipeline R&D
Pipeline
SGK1 Inhibition
Clinical Studies
Publications
Presentations
Focus Areas
Long QT Syndrome (LQTS)
Heart Failure
Atrial Fibrillation
Acquired Long QT
News & Info
Press Releases
Shared Stories & Blog
Contact
Region
Canada: English
Canada: Français
United States
Folder: About Us
Back
Thryv Team
Board of Directors
Scientific Advisory Board
Our Investors
Join Us
Folder: Pipeline R&D
Back
Pipeline
SGK1 Inhibition
Clinical Studies
Publications
Presentations
Folder: Focus Areas
Back
Long QT Syndrome (LQTS)
Heart Failure
Atrial Fibrillation
Acquired Long QT
Folder: News & Info
Back
Press Releases
Shared Stories & Blog
Contact
Folder: Region
Back
Canada: English
Canada: Français
United States

Thryv Therapeutics Inc.

999 Blvd. De Maisonneuve West, Suite 1250, Montreal, Quebec | admin@thryvtrx.com | +1 (514) 973-0915

© Thryv Therapeutics Inc. All rights reserved. Privacy Policy. Terms of Use.